BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 19231116)

  • 1. Effects of high dose oestrogen therapy on circulating inflammatory markers.
    Wilson R; Spiers A; Ewan J; Johnson P; Jenkins C; Carr S
    Maturitas; 2009 Mar; 62(3):281-6. PubMed ID: 19231116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of oestrogen on cytokine and antioxidant levels in male to female transsexual patients.
    Wilson R; Jenkins C; Miller H; Carr S
    Maturitas; 2006 Aug; 55(1):14-8. PubMed ID: 16446062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women.
    Vehkavaara S; Silveira A; Hakala-Ala-Pietilä T; Virkamäki A; Hovatta O; Hamsten A; Taskinen MR; Yki-Järvinen H
    Thromb Haemost; 2001 Apr; 85(4):619-25. PubMed ID: 11341495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of oral and transdermal hormone replacement therapy on C-reactive protein levels and other inflammatory markers in women with high risk of thrombosis.
    Eilertsen AL; Høibraaten E; Os I; Andersen TO; Sandvik L; Sandset PM
    Maturitas; 2005 Oct; 52(2):111-8. PubMed ID: 16186073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of the route of oestrogen administration on serum levels of cortisol-binding globulin and total cortisol.
    Qureshi AC; Bahri A; Breen LA; Barnes SC; Powrie JK; Thomas SM; Carroll PV
    Clin Endocrinol (Oxf); 2007 May; 66(5):632-5. PubMed ID: 17492949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High C-reactive protein levels are associated with oral hormonal menopausal therapy but not with intrauterine levonorgestrel and transdermal estradiol.
    Blumenfeld Z; Boulman N; Leiba R; Siegler E; Shachar S; Linn R; Levy Y
    Scand J Clin Lab Invest; 2007; 67(3):257-63. PubMed ID: 17454839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Plasma levels of total cholesterol, LDL-cholesterol, and HDL-cholesterol in postmenopausal women during 12 months' oral administration of dydrogesterone or medroxyprogesterone combined with continuous transdermal supplementation of 17beta-estradiol].
    Milewicz T; Kostecka A; Rogatko I; Sztefko K; Kwiatkowska-Panek E; Radowick S; Krzysiek J
    Przegl Lek; 2007; 64(2):65-9. PubMed ID: 17892034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral but not transdermal estrogen replacement therapy changes the composition of plasma lipoproteins.
    Vrablik M; Fait T; Kovar J; Poledne R; Ceska R
    Metabolism; 2008 Aug; 57(8):1088-92. PubMed ID: 18640386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of oral conjugated equine estrogen and transdermal estrogen on atherosclerotic vascular disease risk markers and endothelial function in healthy postmenopausal women.
    Ho JY; Chen MJ; Sheu WH; Yi YC; Tsai AC; Guu HF; Ho ES
    Hum Reprod; 2006 Oct; 21(10):2715-20. PubMed ID: 16807281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the route of oestrogen administration on IGF-1 and IGFBP-3 in healthy postmenopausal women: results from a randomized placebo-controlled study.
    Sonnet E; Lacut K; Roudaut N; Mottier D; Kerlan V; Oger E
    Clin Endocrinol (Oxf); 2007 May; 66(5):626-31. PubMed ID: 17492948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipids and clotting factors during low dose transdermal estradiol/norethisterone use.
    Brynhildsen J; Hammar M
    Maturitas; 2005 Apr; 50(4):344-52. PubMed ID: 15780536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations of plasma pro-inflammatory cytokines, fibrinogen, viscosity and C-reactive protein with cardiovascular risk factors and social deprivation: the fourth Glasgow MONICA study.
    Welsh P; Woodward M; Rumley A; Lowe G
    Br J Haematol; 2008 Jun; 141(6):852-61. PubMed ID: 18371109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different effects of transdermal and oral hormone replacement therapy on the renin-angiotensin system, plasma bradykinin level, and blood pressure of normotensive postmenopausal women.
    Ichikawa J; Sumino H; Ichikawa S; Ozaki M
    Am J Hypertens; 2006 Jul; 19(7):744-9. PubMed ID: 16814131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effects of hormone replacement therapy (HRT) on lipid metabolism in the menopause].
    Camilli A; Di Benedetto L; Camilli FM; Ermini M
    Minerva Ginecol; 1997 May; 49(5):199-202. PubMed ID: 9304079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in hemostatic variables induced by estrogen replacement therapy: comparison of transdermal and oral administration in a crossover-designed study.
    Fait T; Vrablik M; Zizka Z; Kostirova M
    Gynecol Obstet Invest; 2008; 65(1):47-51. PubMed ID: 17713346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of effects of sequential transdermal administration versus oral administration of estradiol plus norethisterone acetate on serum NO levels in postmenopausal women.
    Kurtay G; Ozmen B; Erguder I
    Maturitas; 2006 Jan; 53(1):32-8. PubMed ID: 16325022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose continuous combinations of hormone therapy and biochemical surrogate markers for vascular tone and inflammation: transdermal versus oral application.
    Mueck AO; Genazzani AR; Samsioe G; Vukovic-Wysocki I; Seeger H
    Menopause; 2007; 14(6):978-84. PubMed ID: 17595593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized trial of effects of continuous combined HRT on markers of lipids and coagulation in women with acute coronary syndromes: WHISP Pilot Study.
    Collins P; Flather M; Lees B; Mister R; Proudler AJ; Stevenson JC;
    Eur Heart J; 2006 Sep; 27(17):2046-53. PubMed ID: 16899475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different effects of oral and transdermal hormone replacement therapies on factor IX, APC resistance, t-PA, PAI and C-reactive protein--a cross-sectional population survey.
    Lowe GD; Upton MN; Rumley A; McConnachie A; O'Reilly DS; Watt GC
    Thromb Haemost; 2001 Aug; 86(2):550-6. PubMed ID: 11522002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic syndrome in postmenopausal women: the influence of oral or transdermal estradiol on inflammation and coagulation markers.
    Chu MC; Cushman M; Solomon R; Lobo RA
    Am J Obstet Gynecol; 2008 Nov; 199(5):526.e1-7. PubMed ID: 18511016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.